NEW YORK TIMES
This is a historic moment and a show, that with or without the U.S., countries can work together.
After over three years of negotiations, member states have reached a legally binding agreement aimed at bolstering global preparedness for future pandemics. The treaty, shaped by the devastating impact of COVID-19, seeks to enhance international coordination and resilience against emerging pathogens.
Key provisions include establishing a pathogen access and benefit-sharing system, diversifying global research capacities, and creating a robust global supply chain and logistics network. The agreement also emphasizes strengthening health systems’ readiness.
Despite the United States withdrawing from negotiations earlier this year, the agreement is seen as a significant victory for multilateral cooperation. One global health expert described the deal as “a historic moment and a show, that with or without the U.S., countries can work together.”
However, advocacy groups have expressed cautious optimism, noting the treaty’s reliance on voluntary compliance and the lack of strict enforcement mechanisms. The final proposal will be discussed at the upcoming health assembly in May.